Osteoporosis & Jaw Bone Density
Osteoporosis affects the jaw the same way it affects the hip and spine. Postmenopausal women with osteoporosis have measurably lower alveolar bone density, faster periodontal attachment loss, and higher tooth loss rates. Bisphosphonates protect jaw bone but introduce a small risk of medication-related osteonecrosis of the jaw (MRONJ) after invasive dental procedures.
The Connection
Estrogen loss reduces osteoblast activity systemically, including in the jaw. Periodontitis bone loss is amplified, and tooth-supporting bone may resorb after extractions. The mouth is also one of the easiest places to detect osteoporosis-related bone changes on routine dental imaging.
Why Coordination Matters
Endocrinologists prescribing bisphosphonates should coordinate with dentists before any planned extractions or implants. Dentists should assess osteoporosis risk in postmenopausal women and refer for DEXA when appropriate.
What to Watch For
- Tooth mobility in postmenopausal women
- Bone loss visible on dental X-rays
- Receding gums
Frequently Asked Questions
Does osteoporosis affect my teeth?
Yes — it accelerates jaw bone loss, periodontal attachment loss, and tooth loss in postmenopausal women.
Are dental implants safe if I take bisphosphonates?
Generally yes for oral bisphosphonates, with low MRONJ risk; IV bisphosphonates carry higher risk and require careful coordination between dentist and endocrinologist.